Chin‐Chuan Hung

1.7k total citations
59 papers, 1.3k citations indexed

About

Chin‐Chuan Hung is a scholar working on Oncology, Molecular Biology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Chin‐Chuan Hung has authored 59 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Oncology, 24 papers in Molecular Biology and 14 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Chin‐Chuan Hung's work include Drug Transport and Resistance Mechanisms (37 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Cancer therapeutics and mechanisms (11 papers). Chin‐Chuan Hung is often cited by papers focused on Drug Transport and Resistance Mechanisms (37 papers), Pharmacological Effects and Toxicity Studies (14 papers) and Cancer therapeutics and mechanisms (11 papers). Chin‐Chuan Hung collaborates with scholars based in Taiwan, United States and China. Chin‐Chuan Hung's co-authors include Horng‐Huei Liou, John Jen Tai, Yow‐Wen Hsieh, Chun‐Jung Lin, Yu‐Ning Teng, Chih‐Cheng Chen, Charles C. N. Wang, Tsung-Jen Hsieh, Ming‐Jen Lee and Chee‐Jen Chang and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Scientific Reports.

In The Last Decade

Chin‐Chuan Hung

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chin‐Chuan Hung Taiwan 21 544 487 436 373 199 59 1.3k
Nina Hanke Germany 20 193 0.4× 158 0.3× 299 0.7× 126 0.3× 308 1.5× 40 1.1k
Noriko Koyabu Japan 21 646 1.2× 379 0.8× 301 0.7× 48 0.1× 292 1.5× 31 1.3k
Julie Ducharme Canada 20 272 0.5× 153 0.3× 323 0.7× 75 0.2× 341 1.7× 45 1.3k
Masayuki Nadai Japan 20 500 0.9× 249 0.5× 331 0.8× 58 0.2× 326 1.6× 106 1.3k
Linda B. Tabas United States 16 499 0.9× 217 0.4× 247 0.6× 147 0.4× 57 0.3× 17 911
John G. Page United States 21 234 0.4× 234 0.5× 532 1.2× 107 0.3× 481 2.4× 43 1.7k
Boting Zhou China 18 223 0.4× 277 0.6× 285 0.7× 261 0.7× 72 0.4× 35 848
Andrew Acheampong United States 22 73 0.1× 232 0.5× 208 0.5× 152 0.4× 100 0.5× 36 1.5k
Anita Rudy United States 20 89 0.2× 141 0.3× 208 0.5× 132 0.4× 80 0.4× 31 938
Vincent Tong Canada 12 91 0.2× 303 0.6× 192 0.4× 176 0.5× 137 0.7× 20 647

Countries citing papers authored by Chin‐Chuan Hung

Since Specialization
Citations

This map shows the geographic impact of Chin‐Chuan Hung's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chin‐Chuan Hung with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chin‐Chuan Hung more than expected).

Fields of papers citing papers by Chin‐Chuan Hung

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chin‐Chuan Hung. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chin‐Chuan Hung. The network helps show where Chin‐Chuan Hung may publish in the future.

Co-authorship network of co-authors of Chin‐Chuan Hung

This figure shows the co-authorship network connecting the top 25 collaborators of Chin‐Chuan Hung. A scholar is included among the top collaborators of Chin‐Chuan Hung based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chin‐Chuan Hung. Chin‐Chuan Hung is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Su, Ching‐Hui, Hsiao‐Jung Tseng, Chan‐Yen Kuo, et al.. (2025). Comparisons of efficacy and safety of immunotherapies for Alzheimer’s disease treatment: A network meta-analysis of randomised controlled trials. Clinical Medicine. 25(4). 100336–100336. 1 indexed citations
2.
3.
4.
Yu, Cheng‐Ping, et al.. (2024). Discovery of oral chemotherapeutic reversal agents for treating multidrug resistance cancer. European Journal of Pharmacology. 977. 176682–176682. 2 indexed citations
5.
Kuo, Chan‐Yen, Keng‐Chang Tsai, Ping‐Chung Kuo, et al.. (2023). Novel (-)-arctigenin derivatives inhibit signal transducer and activator of transcription 3 phosphorylation and P-glycoprotein function resensitizing multidrug resistant cancer cells in vitro and in vivo. European Journal of Pharmacology. 960. 176146–176146. 4 indexed citations
6.
7.
Lin, Yu-Chao, et al.. (2023). Method Development for Determination of Doripenem in Human Plasma via Capillary Electrophoresis Coupled with Field-Enhanced Sample Stacking and Sweeping. International Journal of Molecular Sciences. 24(18). 13751–13751. 4 indexed citations
8.
Kuo, Chan‐Yen, et al.. (2023). Pinostrobin and Tectochrysin Conquer Multidrug-Resistant Cancer Cells via Inhibiting P-Glycoprotein ATPase. Pharmaceuticals. 16(2). 205–205. 10 indexed citations
9.
Kuo, Chan‐Yen, et al.. (2022). Pharmacological Interventions for Excessive Daytime Sleepiness in Adults with Narcolepsy: A Systematic Review and Network Meta-Analysis. Journal of Clinical Medicine. 11(21). 6302–6302. 4 indexed citations
10.
11.
Wang, Charles C. N., et al.. (2020). Identification of GSN and LAMC2 as Key Prognostic Genes of Bladder Cancer by Integrated Bioinformatics Analysis. Cancers. 12(7). 1809–1809. 20 indexed citations
12.
Hung, Chin‐Chuan, Chien‐Yu Chen, Yu‐Chieh Wu, et al.. (2020). Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors. European Journal of Medicinal Chemistry. 201. 112422–112422. 11 indexed citations
13.
14.
Ling, Yong, Yu‐Ning Teng, Shi Chen, et al.. (2018). Development of novel amino-quinoline-5,8-dione derivatives as NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with potent antiproliferative activities. European Journal of Medicinal Chemistry. 154. 199–209. 31 indexed citations
15.
16.
Chen, Chien‐Yu, et al.. (2016). Structure−activity relationship study of novel 2-aminobenzofuran derivatives as P-glycoprotein inhibitors. European Journal of Medicinal Chemistry. 125. 1023–1035. 19 indexed citations
17.
Chen, Chien‐Yu, et al.. (2016). Synthesis and bioevaluation of novel benzodipyranone derivatives as P-glycoprotein inhibitors for multidrug resistance reversal agents. European Journal of Medicinal Chemistry. 118. 219–229. 24 indexed citations
18.
Wu, Tony, et al.. (2009). Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: An open-label multicenter study. Epilepsy & Behavior. 16(3). 468–474. 33 indexed citations
19.
Hung, Chin‐Chuan, Chih‐Cheng Chen, Chun‐Jung Lin, & Horng‐Huei Liou. (2008). Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenetics and Genomics. 18(5). 390–402. 48 indexed citations
20.
Lin, Chun‐Jung, et al.. (2007). Association of Galactose Single‐Point Test Levels and Phenytoin Metabolic Polymorphisms with Gingival Hyperplasia in Patients Receiving Long‐Term Phenytoin Therapy. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 28(1). 35–41. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Hanke Breakdown of academic impact, for papers by Noriko Koyabu Breakdown of academic impact, for papers by Julie Ducharme Breakdown of academic impact, for papers by Masayuki Nadai Breakdown of academic impact, for papers by Linda B. Tabas Breakdown of academic impact, for papers by John G. Page Breakdown of academic impact, for papers by Boting Zhou Breakdown of academic impact, for papers by Andrew Acheampong Breakdown of academic impact, for papers by Anita Rudy Breakdown of academic impact, for papers by Vincent Tong
Rankless by CCL
2026